Synlab AG
XETRA:SYAB
Synlab AG
XETRA:SYAB
Price:
10.44 EUR
-0.57%
Market Closed
Updated:
May 4, 2024
Synlab AG
Operating Income
|
Synlab AG
Operating Income Peer Comparison
Comparables:
F
FME
F
FRE
V3V
E
1846
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Synlab AG
XETRA:SYAB
|
Operating Income
€104.7m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Operating Income
€1.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-3%
|
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Operating Income
€1.2B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-9%
|
|
|
Vita 34 AG
XETRA:V3V
|
Operating Income
-€22.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Operating Income
HK$194.1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
See Also
What is Synlab AG's Operating Income?
Operating Income
104.7m
EUR
104.7m
EUR
Based on the financial report for Dec 31, 2023, Synlab AG's Operating Income amounts to 104.7m EUR.
What is Synlab AG's Operating Income growth rate?
Operating Income CAGR 3Y
-38%
-38%
Over the last year, the Operating Income growth was -75%. The average annual Operating Income growth rates for Synlab AG have been -38% over the past three years .
You don't have any saved screeners yet
